• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Ischemic Stroke Surgery Market

    ID: MRFR/HC/9493-CR
    136 Pages
    Rahul Gotadki
    October 2022

    Ischemic Stroke Surgery Market Research Report Information by Type of Surgery (Thrombectomy, Revascularization Surgery, Carotid Endarterectomy and Angioplasty), by Product Type (Catheter, Aspiration System, Guidewire, Microcatheter and Others), by End User (Hospitals and Clinics, Ambulatory Surgical Centers and Others) Region (North America, Europe, Asia-Pacific, and Rest of the World)—Forecast till 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Ischemic Stroke Surgery Market Research Report—Global Forecast till 2032 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    Ischemic Stroke Surgery Market Summary

    As per Market Research Future Analysis, the Global Ischemic Stroke Surgery Market was valued at USD 3.84 Billion in 2023 and is projected to reach USD 6.77 Billion by 2032, growing at a CAGR of 6.52% from 2024 to 2032. The market is driven by increasing physical inactivity, the launch of advanced products, and a rising demand for minimally invasive procedures. However, challenges such as a lack of medical facilities in developing countries and a shortage of skilled professionals may hinder growth. The COVID-19 pandemic moderately disrupted production and revenue in 2020, but recovery was noted in 2021 as supply chains were restored.

    Key Market Trends & Highlights

    Key trends influencing the ischemic stroke surgery market include technological advancements and demographic shifts.

    • Market Size in 2023: USD 3.84 Billion
    • Projected Market Size by 2032: USD 6.77 Billion
    • CAGR from 2024 to 2032: 6.52%
    • Major Growth Drivers: Increase in sedentary lifestyles and demand for minimally invasive procedures

    Market Size & Forecast

    2023 Market Size USD 3.84 Billion
    2024 Projected Market Size USD 4.08 Billion
    2032 Projected Market Size USD 6.77 Billion

    Major Players

    Stryker (US), Medtronic Plc (Ireland), Johnson & Johnson Services Inc. (US), Boston Scientific Corporation (US), Penumbra, Inc. (US), Abbott Laboratories (US), Koninklijke Philips N.V. (Netherlands), Imperative Care (US), Phenox GmbH (Germany)

    Ischemic Stroke Surgery Market Trends

    The Global Ischemic Stroke Surgery Market is poised for growth as advancements in surgical techniques and technologies enhance patient outcomes and recovery times.

    U.S. National Institutes of Health (NIH)

    Ischemic Stroke Surgery Market Drivers

    Aging Population

    The aging global population is a critical driver of the Global Ischemic Stroke Surgery Market Industry. As individuals age, the risk of ischemic stroke increases significantly due to factors such as hypertension, diabetes, and other comorbidities. This demographic shift necessitates a robust healthcare response, particularly in surgical interventions for stroke management. With a larger segment of the population requiring surgical treatment, the market is poised for growth. The projected increase in market size from 4.08 USD Billion in 2024 to 8.18 USD Billion by 2035 underscores the urgency of addressing the needs of this aging demographic.

    Market Growth Trends

    Growing Awareness and Education

    There is a notable increase in awareness and education regarding stroke symptoms and the importance of timely intervention, which is positively impacting the Global Ischemic Stroke Surgery Market Industry. Public health campaigns and educational programs are encouraging individuals to seek immediate medical attention when experiencing stroke symptoms. This heightened awareness leads to earlier diagnosis and treatment, which is crucial for successful surgical outcomes. As more patients become informed about their options, the demand for ischemic stroke surgeries is likely to rise, contributing to the overall growth of the market.

    Increasing Healthcare Expenditure

    The rise in global healthcare expenditure is a significant factor influencing the Global Ischemic Stroke Surgery Market Industry. Governments and private sectors are investing more in healthcare infrastructure, leading to enhanced access to surgical interventions for ischemic stroke patients. This increased funding allows for the procurement of advanced surgical equipment and training for healthcare professionals. As healthcare systems prioritize stroke management, the market is expected to benefit from improved facilities and resources. This trend aligns with the projected growth of the market, reaching 4.08 USD Billion in 2024 and continuing to expand towards 8.18 USD Billion by 2035.

    Rising Incidence of Ischemic Stroke

    The increasing prevalence of ischemic stroke globally is a primary driver for the Global Ischemic Stroke Surgery Market Industry. According to health statistics, ischemic strokes account for approximately 87 percent of all strokes, leading to a growing demand for surgical interventions. As the global population ages, the incidence of ischemic strokes is projected to rise, necessitating advancements in surgical techniques and technologies. This trend is expected to contribute significantly to the market's growth, with the industry projected to reach 4.08 USD Billion in 2024 and potentially 8.18 USD Billion by 2035, reflecting a compound annual growth rate of 6.53% from 2025 to 2035.

    Technological Advancements in Surgical Procedures

    Innovations in surgical techniques and technologies are transforming the Global Ischemic Stroke Surgery Market Industry. Minimally invasive procedures, such as endovascular thrombectomy, have shown promising results in improving patient outcomes. These advancements not only enhance the efficacy of surgeries but also reduce recovery times, thereby increasing patient throughput. The integration of robotic-assisted surgery and advanced imaging techniques further supports the precision of interventions. As hospitals and surgical centers adopt these technologies, the market is likely to expand, driven by the demand for improved surgical outcomes and patient satisfaction.

    Market Segment Insights

    Regional Insights

    Key Companies in the Ischemic Stroke Surgery Market market include

    Industry Developments

      • In February 2022, Imperative Care launched the Zoom POD for stroke therapy. The Zoom POD is the world's first and only sterile field clot filtration device, allowing for speedier clot collection during essential mechanical thrombectomy treatments for patients suffering from ischemic stroke.
      • In February 2022, Johnson & Johnson Services, Inc. launched EMBOGUAR, a next-generation balloon guide catheter for use in endovascular therapies, notably those for patients suffering from acute ischemic stroke.
      • In October 2021, Phenox GmbH launched the pRESET 6-50 mechanical thrombectomy device to broaden its technological range for acute ischemic stroke across the globe.
      • In September 2021, Abbott acquired Walk Vascular, LLC (US), a medical device company with a minimally invasive mechanical aspiration system designed to remove peripheral blood clots. This acquisition will help to expand the company's peripheral vascular offerings.
      • In February 2021, Phenox GmbH expands with the creation of a new office in the UK to increase its presence in important markets around Europe.

    Future Outlook

    Ischemic Stroke Surgery Market Future Outlook

    The Ischemic Stroke Surgery Market is projected to grow at a 6.53% CAGR from 2024 to 2035, driven by advancements in surgical techniques, increasing prevalence of ischemic strokes, and enhanced healthcare infrastructure.

    New opportunities lie in:

    • Invest in AI-driven surgical tools to improve precision and outcomes.
    • Develop minimally invasive techniques to reduce recovery times and costs.
    • Expand telemedicine services for pre- and post-operative care to enhance patient access.

    By 2035, the Ischemic Stroke Surgery Market is expected to be robust, reflecting significant advancements and increased accessibility.

    Market Segmentation

    Report Overview

    Global Ischemic Stroke Surgery Market, by Region
    • {"North America"=>["US", "Canada"]}
    • {"Europe"=>["Germany", "France", "UK", "Italy", "Spain", "Rest of Europe"]}
    • {"Asia-Pacific"=>["China", "India", "Japan", "Australia"]}
    • Rest of the World
    Global Ischemic Stroke Surgery Market, by End User
    • Hospitals And Clinics
    • Ambulatory Surgical Centers
    • Others
    Global Ischemic Stroke Surgery Market, by Product Type
    • Catheter
    • Aspiration System
    • Guidewire
    • Microcatheter
    • Others
    Global Ischemic Stroke Surgery Market, by Type of Surgery
    • Thrombectomy
    • Revascularization Surgery
    • Carotid Endarterectomy
    • Angioplasty
    • Others

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 3.84 (USD Billion)
    Market Size 2024 4.08 (USD Billion)
    Market Size 2032 6.77 (USD Billion)
    Compound Annual Growth Rate (CAGR) 6.52 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
      Geographies Covered   North America, Europe, Asia-Pacific, Rest of the World
      Key Vendors   Stryker (US), Medtronic PLC (Ireland), Johnson & Johnson Services Inc. (US), Boston Scientific Corporation (US), Penumbra, Inc. (US), Abbott Laboratories (US), Koninklijke Philips N.V. (Netherlands), Imperative Care (US), Abbott Laboratories (US), and Phenox GmbH (Germany)
      Key Market Opportunities  R&D activities and investments
      Key Market Drivers  Rise in physical inactivity and sedentary lifestyles • Adoption and launch of technologically advanced products Rising demand for minimally invasive procedures

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch
    Leave a Comment

    FAQs

    How Big is the Ischemic Stroke Surgery market?

    The Ischemic Stroke Surgery Market is anticipated to reach USD 6.77 billion by 2035 and register a CAGR of 6.52% during the forecast period of 2024 to 2032.

    Who are the key competitors in the market of Ischemic Stroke Surgery?

    Stryker (US), Medtronic PLC (Ireland), Johnson & Johnson Services Inc. (US), Boston Scientific Corporation (US), Penumbra, Inc. (US), Abbott Laboratories (US), Koninklijke Philips N.V. (Netherlands), Imperative Care (US), Abbott Laboratories (US), and Phenox GmbH (Germany) are the key players in the market of Ischemic Stroke Surgery

    Which region is predicted to have the largest market share of Ischemic Stroke Surgery

    North America is predicted to lead the market of Ischemic Stroke Surgery

    What are the key factors driving the market of Ischemic Stroke Surgery?

    Rise in physical inactivity and sedentary lifestyles and Adoption and launch of technologically advanced products are driving the market growth

    Which factors may act as market deterrents Ischemic Stroke Surgery?

    Lack of medical facilities and Shortage of skilled professionals are the market deterrents.

    1. OF CONTENTS
    2. EXECUTIVE SUMMARY
    3. OVERVIEW
    4. MARKET INTRODUCTION
    5. DEFINITION
    6. SCOPE OF THE STUDY
    7. RESEARCH OBJECTIVE
    8. MARKET STRUCTURE
    9. ASSUMPTIONS & LIMITATIONS
    10. RESEARCH METHODOLOGY
      1. DATA MINING
      2. SECONDARY RESEARCH
      3. PRIMARY RESEARCH
      4. BREAKDOWN OF PRIMARY RESPONDENTS
      5. FORECASTING TECHNIQUES
      6. RESEARCH METHODOLOGY
    11. FOR MARKET SIZE ESTIMATION
      1. BOTTOM-UP APPROACH
        1. TOP-DOWN APPROACH
      2. DATA TRIANGULATION
      3. VALIDATION
    12. MARKET DYNAMICS
      1. OVERVIEW
      2. DRIVERS
        1. RISE IN PHYSICAL INACTIVITY AND SEDENTARY LIFESTYLES
        2. ADOPTION AND LAUNCH
    13. OF TECHNOLOGICALLY ADVANCED PRODUCTS
      1. RISING DEMAND FOR MINIMALLY INVASIVE PROCEDURES
      2. RESTRAINTS
        1. LACK OF MEDICAL
    14. FACILITIES
    15. SHORTAGE OF SKILLED PROFESSIONALS
      1. OPPORTUNITIES
        1. R&D ACTIVITIES AND INVESTMENTS
    16. MARKET FACTOR ANALYSIS
      1. VALUE CHAIN ANALYSIS
        1. R&D
        2. MANUFACTURING
        3. DISTRIBUTION AND SALES
        4. POST-SALES MONITORING
      2. PORTER’S FIVE FORCES MODEL
        1. THREAT OF NEW ENTRANTS
        2. BARGAINING POWER
    17. OF SUPPLIERS
    18. THREAT OF SUBSTITUTES
    19. BARGAINING POWER OF BUYERS
      1. INTENSITY OF RIVALRY
      2. IMPACT OF COVID-19 ON THE GLOBAL ISCHEMIC STROKE SURGERY
    20. MARKET
    21. IMPACT ON SUPPLY CHAIN
    22. IMPACT ON PRODUCTION
    23. IMPACT ON DEMAND
    24. EPIDEMIOLOGY ANALYSIS
    25. INCIDENCE & PREVALENCE
      1. NUMBER OF PROCEDURES FOR THROMBECTOMY
      2. REGULATORY ANALYSIS/HEALTHCARE SYSTEM
    26. GLOBAL ISCHEMIC STROKE
    27. SURGERY MARKET, BY TYPE OF SURGERY
      1. OVERVIEW
      2. THROMBECTOMY
      3. REVASCULARIZATION SURGERY
      4. CAROTID ENDARTERECTOMY
      5. ANGIOPLASTY
      6. OTHERS
    28. GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT
    29. TYPE
      1. OVERVIEW
      2. CATHETER
      3. ASPIRATION SYSTEM
      4. GUIDEWIRE
      5. MICROCATHETER
      6. OTHERS
    30. GLOBAL ISCHEMIC STROKE
    31. SURGERY MARKET, BY END USER
      1. OVERVIEW
      2. HOSPITALS AND CLINICS
      3. AMBUATORY SURGICAL CENTRES
      4. OTHERS
    32. GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY REGION
      1. OVERVIEW
      2. NORTH AMERICA
        1. US
        2. CANADA
      3. EUROPE
        1. GERMANY
        2. UK
        3. FRANCE
        4. ITALY
        5. SPAIN
        6. REST OF EUROPE
      4. ASIA PACIFIC
        1. JAPAN
        2. CHINA
        3. INDIA
        4. AUSTRALIA
        5. SOUTH KOREA
        6. REST OF ASIA PACIFIC
      5. REST OF THE WORLD
        1. MIDDLE EAST
        2. AFRICA
        3. LATIN AMERICA
    33. COMPETITIVE LANDSCAPE
      1. OVERVIEW
      2. MARKET SHARE ANAYISIS
      3. COMPETITIVE BENCHMARKING
      4. MAJOR GROWTH STRATEGY IN THE GLOBAL ISCHEMIC
    34. STROKE SURGERY MARKET
    35. THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL ISCHEMIC STROKE
    36. SURGERY MARKET
    37. KEY DEVELOPMENT ANALYSIS
      1. KEY DEVELOPMENTS & GROWTH STRATEGIES
        1. MERGER & ACQUISITIONS
        2. AGREEMENT/MARKETING STRATEGIES
      2. FINANCIAL MATRIX
        1. SALES (USD MILLION),
    38. RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2021
    39. COMPANY PROFILES
      1. MEDTRONIC PLC
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. SWOT ANALYSIS
        6. KEY STRATEGIES
      2. ABBOTT LABORATORIES
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. KEY STRATEGIES
      3. BOSTON SCIENTIFIC CORPORATION
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. KEY STRATEGIES
      4. CORDIS CORPORATION
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. KEY STRATEGIES
      5. KONINKLIJKE PHILIPS
    40. N.V
    41. COMPANY OVERVIEW
    42. FINANCIAL OVERVIEW
    43. PRODUCTS OFFERED
    44. KEY DEVELOPMENTS
    45. SWOT ANALYSIS
    46. KEY STRATEGIES
    47. STRYKER
    48. COMPANY OVERVIEW
    49. FINANCIAL OVERVIEW
    50. PRODUCTS OFFERED
    51. KEY DEVELOPMENTS
    52. SWOT ANALYSIS
    53. KEY STRATEGIES
    54. IMPERATIVE CARE
    55. COMPANY OVERVIEW
    56. FINANCIAL OVERVIEW
    57. PRODUCTS OFFERED
    58. KEY DEVELOPMENTS
    59. KEY STRATEGIES
    60. JOHNSON & JOHNSON SERVICES, INC.
      1. COMPANY OVERVIEWS
        1. FINANCIAL OVERVIEW
        2. PRODUCTS OFFERED
        3. KEY DEVELOPMENTS
        4. SWOT ANALYSIS
        5. KEY STRATEGIES
      2. PENUMBRA, INC.
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. SWOT ANALYSIS
        6. KEY STRATEGIES
      3. PHENOXYHENOX GMBH
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. KEY STRATEGIES
    61. APPENDIX
      1. REFERENCES
      2. RELATED REPORTS
    62. AND INFORMATION GATHERING PROCESS
    63. FOR THROMBECTOMY, BY COUNTRY (2021)
    64. OF SURGERY, 2018–2035 (USD MILLION)
    65. THROMBECTOMY, BY REGION, 2018–2035 (USD MILLION)
    66. REVASCULARIZATION SURGERY, BY REGION, 2018–2035 (USD MILLION)
    67. SURGERY MARKET, FOR CAROTID ENDARTERECTOMY, BY REGION, 2018–2035 (USD MILLION)
    68. STROKE SURGERY MARKET, FOR ANGIOPLASTY, BY REGION, 2018–2035 (USD MILLION)
    69. STROKE SURGERY MARKET, FOR OTHERS, BY REGION, 2018–2035 (USD MILLION)
    70. STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    71. STROKE SURGERY MARKET, FOR CATHETER, BY REGION, 2018–2035 (USD MILLION)
    72. STROKE SURGERY MARKET, FOR ASPIRATION SYSTEM, BY REGION, 2018–2035 (USD MILLION)
    73. STROKE SURGERY MARKET, FOR GUIDEWIRE, BY REGION, 2018–2035 (USD MILLION)
    74. STROKE SURGERY MARKET, FOR MICROCATHETER, BY REGION, 2018–2035 (USD MILLION)
    75. STROKE SURGERY MARKET, FOR OTHERS, BY REGION, 2018–2035 (USD MILLION)
    76. STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
    77. SURGERY MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2018–2035 (USD MILLION)
    78. STROKE SURGERY MARKET, FOR AMBULATORY SURGERY CENTRES, BY REGION, 2018–2035
    79. (USD MILLION)
    80. GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR OTHERS BY REGION, 2018–2035
    81. (USD MILLION)
    82. GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY REGION, 2018–2035 (USD MILLION)
    83. ISCHEMIC STROKE SURGERY MARKET, BY COUNTRY, 2018–2035 (USD MILLION)
    84. ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
    85. ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    86. ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
    87. STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
    88. STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    89. STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
    90. SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
    91. SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    92. SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
    93. BY COUNTRY, 2018–2035 (USD MILLION)
    94. BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
    95. BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    96. BY END USER, 2018–2035 (USD MILLION)
    97. BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
    98. BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    99. BY END USER, 2018–2035 (USD MILLION)
    100. OF SURGERY, 2018–2035 (USD MILLION)
    101. TYPE, 2018–2035 (USD MILLION)
    102. –2035 (USD MILLION)
    103. –2035 (USD MILLION)
    104. (USD MILLION)
    105. FRANCE: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
    106. STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
    107. STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    108. STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
    109. SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
    110. SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    111. SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
    112. MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
    113. MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    114. MARKET, BY END USER, 2018–2035 (USD MILLION)
    115. BY COUNTRY, 2018-2035 (USD MILLION)
    116. TYPE OF SURGERY, 2018–2035 (USD MILLION)
    117. BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    118. BY END USER, 2018–2035 (USD MILLION)
    119. TYPE OF SURGERY, 2018–2035 (USD MILLION)
    120. PRODUCT TYPE, 2018–2035 (USD MILLION)
    121. END USER, 2018–2035 (USD MILLION)
    122. OF SURGERY, 2018–2035 (USD MILLION)
    123. PRODUCT TYPE, 2018–2035 (USD MILLION)
    124. END USER, 2018–2035 (USD MILLION)
    125. OF SURGERY, 2018–2035 (USD MILLION)
    126. PRODUCT TYPE, 2018–2035 (USD MILLION)
    127. END USER, 2018–2035 (USD MILLION)
    128. OF SURGERY, 2018–2035 (USD MILLION)
    129. BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    130. BY END USER, 2018–2035 (USD MILLION)
    131. BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
    132. BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    133. BY END USER, 2018–2035 (USD MILLION)
    134. MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
    135. MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    136. MARKET, BY END USER, 2018–2035 (USD MILLION)
    137. MARKET, BY REGION, 2018-2035(USD MILLION)
    138. MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
    139. MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    140. MARKET, BY END USER, 2018–2035 (USD MILLION)
    141. BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
    142. BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    143. BY END USER, 2018–2035 (USD MILLION)
    144. BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
    145. BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    146. BY END USER, 2018–2035 (USD MILLION)
    147. BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
    148. BY PRODUCT TYPE, 2018–2035 (USD MILLION)
    149. BY END USER, 2018–2035 (USD MILLION)
    150. SURGERY MARKET
    151. MOST ACTIVE PLAYERS IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
    152. APPROVAL
    153. MERGER & ACQUISITIONS
    154. PRODUCTS OFFERED
    155. ABBOTT LABORATORIES: KEY DEVELOPMENTS
    156. PRODUCTS OFFERED
    157. KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED'

    Ischemic Stroke Surgery Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027